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CC BY-NC-ND license (http://creativeBackground: Acute kidney injury (AKI) is common in preterm infants and is associated with high
mortality and morbidity. New biomarkers for the early detection of AKI have been identified.
Specifically, urinary neutrophil gelatinase-associated lipocalin (uNGAL) is a new and powerful
biomarker for AKI and sepsis. Our study evaluated the reference range of uNGAL in healthy ne-
onates in Taiwan.
Methods: This study examined 24 preterm and 38 term infants without clinical complications.
Urine samples were collected and the uNGAL values were measured at postnatal age (PNA) 3
days, 7 days, 14 days, and 21 days in the preterm infants and at PNA 3 days in the term infants.
The uNGAL values were tested using enzyme-linked immunosorbent assay.
Results: The median uNGAL values in the preterm infants at PNA 3 days, 7 days, 14 days, and
21 days were 41.52 ng/mL, 35.82 ng/mL, 43.79 ng/mL, and 30.85 ng/mL, respectively. The me-
dian value at PNA 3 days in the term infants was 88.1 ng/mL. No significant differences asso-
ciated with gestational age, birth body weight, or PNA were observed among the preterm
infants. However, the uNGAL values in the female term infants were higher than those int of Pediatrics, National Taiwan University Hospital and National Taiwan University College of
Road, Taipei, Taiwan.
tw (W.-S. Hsieh).
015.09.003
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208 C.-N. Chen et althe male term infants (p Z 0.003).
Conclusion: This study presents preliminary data on uNGAL levels in neonates in Taiwan. A
large-scale study investigating the correlations between uNGAL and with gestational age, birth
body weight, sex, and PNA is recommended.
Copyright ª 2015, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).1. Introduction
New biomarkers have been developed for detecting renal
function impairment in neonates. These biomarkers are
used in the early detection of acute kidney injury (AKI) and
are less invasive.1,2 The survival rate of preterm infants has
also increased with advances in perinatal care and the
development of new biomedical technology.3 However,
preterm infants remain vulnerable to renal impairment
because of their underdeveloped kidneys, with medications
for renal toxicity such as aminoglycoside, indomethacin,
and ibuprofen sometimes being required. Hypotension and
hypoxemia are common in preterm infants during the first
few days of life; these conditions may also contribute to
AKI. The incidence of AKI in neonates is 6e24%, and neo-
nates with AKI may experience long-term complications
such as chronic kidney disease.4,5 Higher mortality and
morbidity rates were found in preterm infants with AKI.6
Therefore, the early detection of AKI is crucial for avoid-
ing further organ damage and extending the lives of infants
with AKI.
Serum creatinine (SCr) and urine output are the main
detectors of AKI.7e9 The true renal function of preterm
infants is difficult to evaluate.10 SCr levels in infants are
unreliable as a detector of AKI in the first few days of life
because they may continue to reflect maternal SCr levels.
Furthermore, SCr levels in infants may not change until
renal function decreases below 25e50% that of normal
levels. In addition, SCr levels are correlated with muscle
mass and sex.1 New methods of identifying AKI in preterm
infants are thus required.
Neutrophil gelatinase-associated lipocalin (NGAL) is a
25-kDa protein that was first discovered by a Danish sci-
entist in 1983,11 and is a novel biomarker used for detecting
AKI. It can be detected in serum and urine specimens and
used as a biomarker for detecting AKI, sepsis, and urinary
tract infections in adults and children.12e18 Serum NGAL
was determined to be related to the occurrence of bron-
chopulmonary dysplasia in preterm infants.19 Levels of
NGAL can be detected a few hours after renal injury, before
the SCr levels become elevated. A strong correlation be-
tween serum and urinary NGAL (uNGAL) concentrations was
reported.12
Although NGAL appears to be a useful biomarker for AKI,
scant reference data on NGAL in preterm infants exist, and
previous studies have yielded conflicting results. Some
studies have correlated NGAL with gestational age (GA),
postnatal age (PNA), and sex, whereas others have revealed
no such associations.1,15,20e22 Furthermore, no studies have
determined the normal levels of uNGAL in Asian neonates.Therefore, our study aimed at determining the reference
ranges of uNGAL in healthy preterm and term neonates in
Taiwan.2. Methods2.1. Participants and NGAL measurement
We conducted a prospective, observational study on ne-
onates admitted to the National Taiwan University Hos-
pital between December 2003 and January 2007. Ninety-
nine neonates were initially enrolled in our study. Thirty-
seven participants with congenital anomalies, proven
(with a positive blood culture) or suspected neonatal
sepsis, maternal infection (if the mother had a urinary
tract infection, fever, or chorioamnionitis), AKI (urine
output < 1 cm3/kg/h for 24 hours),23 prolonged ventilator
use (intubated with mechanical ventilator support for >7
days) or severe hypoxic ischemic encephalopathy, a low
Apgar score (Apgar score < 4 at 1 minute and/or < 7 at 5
minutes after birth), incomplete data (unrecognized or
missing data of clinical parameters in medical records),
post indomethacin treatment or surgical ligation for pat-
ent ductus arteriosus, or necrotizing enterocolitis were
excluded. A total of 62 neonates with no clinical compli-
cations were enrolled and subgrouped into preterm
(n Z 24) and term infants (n Z 38; Figure 1).
All of the preterm infants underwent a renal function
test (verifying that their SCr levels were <1.0 mg/dL) when
possible or had their urine output recorded (verifying an
output of >2 cm3/kg/h) during their hospital stay. The term
infants were admitted to the nursery and had their urine
output recorded at least once on Day 1, two times on Day 2,
and three times on Day 3 as a general routine evaluation of
renal function and hydration. Based on these measure-
ments, we assumed that the infants had normal renal
function and were sufficiently hydrated.
Urine samples were collected from the term infants at
PNA 3 days and from the preterm infants at PNA 3 days, 7
days, 14 days, and 21 days. The preterm infants were
stratified into the following two groups according to GA:
Group 1 (GA < 32 weeks, n Z 11) and Group 2 (GA 32e36
weeks, n Z 13). The term infants comprised Group 3. This
study was approved by the Institutional Review Board of
National Taiwan University Hospital, and written consent
was obtained from the parents of each infant.
Urine samples were collected using urine bags or cotton
balls and were stored at 80C until analysis. The NGAL
values were tested using a sandwich enzyme-linked
Figure 1 Flowchart of the study population. AKI Z acute kidney injury; HIE Z hypoxic ischemic encephalopathy;
hsPDA Z hemodynamically significant patent ductus arteriosus. *Some of them had more than 2 morbidities.
Table 1 Clinical characteristics of the preterm and term
groups.
Preterm Term
Group 1
(n Z 11)
Group 2
(n Z 13)
Group 3
(n Z 38)
GA (wk) 29.2  2.4 32.7  0.9 39  1.1
BBW (g) 1270  330.9 1646  279.2 3244  437
Apgar score
1 min 5.6  1.9 7.2  1.3 8.9  0.2
5 min 7.9  0.7 8.5  1 9  0
Male 5 (45) 8 (62) 26 (68)
Cesarean
section
8 (73) 13 (100) 12 (32)
Surfactant 0 (0) 1 (8) 0 (0)
BPD 1 (9) 0 (0) 0 (0)
Data are presented as mean  SD or n (%).
BBWZ birth body weight; BPDZ bronchopulmonary dysplasia;
GA Z gestational age; SD Z standard deviation.
uNGAL levels in neonates 209immunosorbent assay (ELISA) and biotin-labeled antibody
using Lipocalin-2/NGAL human ELISA kits (BioVendor, Inc.,
Brno, Czech Republic). The laboratory investigator was
blind to the infants’ group allocations and clinical condition
when analyzing the urine samples.
2.2. Statistical analysis
GraphPad Prism Version 6.00 for Windows software
(GraphPad Software, San Diego, CA, USA) was used to
conduct analyses. We used a two-sample t test or Man-
neWhitney U test to compare continuous variables. We
performed a nonparametric KruskaleWallis analysis of
variance test to compare the GA groups. A p value < 0.05
was considered statistically significant.
3. Results
3.1. Patient characteristics
Sixty-two neonates (24 preterm infants and 38 term infants)
were examined in this cohort study. Table 1 summarizes the
characteristics of the study population. All of the neonates
were Taiwanese. Both GA and birth body weight (BBW)
differed significantly among these groups (p < 0.001).
There was one infant with bronchopulmonary dysplasia in
Group 1, and one infant receiving surfactant therapy in
Group 2. They were included because they did not meet the
exclusion criteria and we assumed that they were following
the typical preterm clinical course. The cesarean section
rate was 100% in Group 2, possibly a coincidental result.
3.2. uNGAL values
Table 2 presents the uNGAL values for different GAs. A total
of 104 urine samples were collected from the 62 neonates.The uNGAL values of Groups 1 and 2 were not significantly
different nor were their uNGAL levels at different PNAs. In
addition, the uNGAL values of the preterm and term infants
at PNA 3 days were not significantly different (p Z 0.53;
Figure 2A).
Comparing the difference in uNGAL values between
male and female infants, we found no significant differ-
ence in the preterm group (p Z 0.136) but found a sig-
nificant difference in the term group (p Z 0.003;
Figure 2B).
The uNGAL values of the preterm infants with different
BBWs were also analyzed. No correlation was found be-
tween prematurity with BBW <1500 g and prematurity with
BBW 1500 g. The median levels of uNGAL with BBW
<1500 g and BBW 1500 g were 45.9 ng/mL versus 39.5 ng/
Table 2 Urinary neutrophil gelatinase-associated lip-
ocalin values (ng/mL) stratified by group and postnatal age.
PNA
3 d
PNA
7 d
PNA
14 d
PNA
21 d
p
Preterm
Group 1 Case no. 4 9 7 7
10th percentile 13 17 11 18
Median 56.8 45.6 44.7 32.3 0.77
90th percentile 114 402 349 89
Group 2 Case no. 9 12 9 9
10th percentile 8.6 5.4 6.3 4.7
Median 37.6 34.1 39.8 28.2 0.97
90th percentile 108 259 94 310
Term
Group 3 Case no. 38
10th percentile 12
Median 88.1 NA NA NA NA
90th percentile 244
The p values were determined using the KruskaleWallis test.
PNA Z postnatal age; NA Z not available.
210 C.-N. Chen et almL (p Z 0.77), 45.6 ng/mL versus 33.5 ng/mL (p Z 0.31),
59.9 ng/mL versus 40 ng/mL (p Z 0.18), and 32.3 ng/mL
versus 21.9 ng/mL (p Z 0.29) at PNA 3 days, 7 days, 14
days, and 21 days, respectively.Figure 2 Urinary NGAL values in preterm and term infants.
(A) Data at PNA 3 days (geometric mean with 95% confidence
interval; p Z 0.53). (B) Data at PNA 3 days according to the
preterm or term subgroup and sex (geometric mean with 95%
confidence interval; p Z 0.136 and p Z 0.003 in the preterm
and term groups, respectively, as determined using the
ManneWhitney U test). uNGAL Z urinary neutrophil
gelatinase-associated lipocalin; PNA Z postnatal age.4. Discussion
This study is the fourth to determine a reference range of
uNGAL levels in preterm infants with no clinical compli-
cations and the first to determine a uNGAL reference
range for neonates in Asia (Appendix 1).20,22,24 This study
recorded preliminary uNGAL data for Taiwanese neonates,
with the preterm and term infants at PNA 3 days exhib-
iting similar values. The values determined by this study
are comparable to those of children and adults
worldwide.24
Lavery et al15 conducted the first study on uNGAL levels
in preterm infants in 2008. They examined 20 preterm in-
fants (congenital anomaly cases were excluded), whom
they divided into four groups according to BBW. The results
of their study showed that uNGAL may be correlated with
GA and BBW. Their reported median levels were higher than
those recorded in other studies because some cases in their
study involved complicated clinical conditions such as
necrotizing enterocolitis and indomethacin treatment for
patent ductus arteriosus.
The uNGAL differences found among preterm infants can
be interpreted differently. In our study, no correlation be-
tween uNGAL and GA, BBW, or PNA was observed, sup-
porting the results of Elmas et al.22 Some studies have
posited that renal development may be associated with
uNGAL.20,25 Other urine biomarkers such as kidney injury
molecule-1, cystatin C, beta2 microglobulin (B2mG), and
osteopontin (OPN) have been found to decrease with
increasing GA.1 Thus, further studies are required to
elucidate the associations between these clinical factors.
Notably, higher uNGAL values in female infants have
been found in other studies.1,20 Our findings confirm that
uNGAL levels are much higher in the female infants of the
preterm (median values for male and female infants were
25.5 and 67.8, respectively; p Z 0.136) and term
(p Z 0.003) groups. Askenazi et al1 and Huynh et al20 re-
ported similar findings, although the causes were unclear. A
study by Keijzer-Veen et al26 revealed that kidney growth in
preterm females remained stunted after 20 years. There-
fore, differences in renal development between the sexes
should be considered. Stool fragments or vaginal secretions
may have caused contamination because cotton balls were
used for the urine collections.20
BBW may also contribute to changes in uNGAL levels in
preterm infants15; however, we found no significant rela-
tionship in preterm infants with BBW <1500 g or BBW
1500 g. The levels of some urine biomarkers have been
found to vary with ethnicity; Askenazi et al1 reported that
the levels of OPN and B2mG were higher for detecting AKI in
preterm infants and were independently associated with
white ethnicity. Nevertheless, no clear evidence exists that
white neonates have different uNGAL levels because of
their ethnicity. Because studies on uNGAL levels in Asian
populations are scant, our preliminary data may provide a
basis for further research. Furthermore, although the
relative influence of the confounding factors of GA, BBW,
PNA, and sex is unclear, the uNGAL values in patients with
AKI or sepsis are much higher than in the general popula-
tion.12,25,27 Therefore, it may be necessary to correct
uNGAL values by using other clinical characteristics.
uNGAL levels in neonates 211This study is the first to report preliminary data on
uNGAL levels in neonates with no complications in Taiwan
and is the first to present preterm and term neonatal
reference data for an Asian cohort. In general, blood sam-
ples of SCr or blood urea nitrogen have been required for
renal function evaluations in clinical practice. By contrast,
urine samples for preterm morbidity evaluations are
noninvasive and avoid blood vessel punctures, which is
critical for preventing bloodstream infections in infants
with immunocompromised prematurity. Changes in uNGAL
also occur earlier than increases in SCr.21 Medical man-
agement could be adjusted to provide early intervention,
thus preventing AKI progression in infants.
A limitation of our study was the small sample size,
particularly of preterm infants with extremely low birth
weights; because most of these infants had complications
with sepsis or AKI, they were excluded from the study.
Therefore, the data mainly reflect uNGAL levels in larger
babies (BBW  1000 g). In addition, the urine samples were
not collected daily, and only four measurements were
collected. The reasons for dynamic changes in the uNGAL
levels of premature infants after correcting for age remain
unclear. Previous studies of uNGAL levels in preterm infants
have reported wide variations because of different inclu-
sion criteria and uNGAL evaluation protocols.1,15,20e22
Therefore, we recommend additional large-scale studies
to validate the relationship between uNGAL and other
clinical characteristics. The cutoff levels for AKI and other
morbidities such as neonatal sepsis and bronchopulmonary
dysplasia should also be investigated because NGAL is
elevated in patients with inflammatory or infected
processes.19
In conclusion, we found that the uNGAL values of pre-
term and term neonates without complications were similar
at PNA 3 days. The levels were higher in female infants but
were not correlated with GA, BBW, or PNA. Further inves-
tigation is necessary to elucidate the association between
NGAL and these clinical factors. A population-based cohort
study is required to establish the normative reference
levels of uNGAL in preterm infants according to sex and GA,
BBW, and PNA ranges.
Conflicts of interest
The content of this paper has not been influenced directly
or indirectly by any actual or potential conflicts of interest.
The authors have no conflicts of interest relevant to this
article.
References
1. Askenazi DJ, Koralkar R, Levitan EB, Goldstein SL, Devarajan P,
Khandrika S, et al. Baseline values of candidate urine acute
kidney injury biomarkers vary by gestational age in premature
infants. Pediatr Res 2011;70:302e6.
2. Libo´rio AB, Branco KM, Torres de Melo Bezerra C. Acute kidney
injury in neonates: from urine output to new biomarkers. Biomed
Res Int 2014;2014:601568.
3. Roberts G, Burnett AC, Lee KJ, Cheong J, Wood SJ,
Anderson PJ, et al. Quality of life at age 18 years after
extremely preterm birth in the post-surfactant era. J Pediatr
2013;163:1008e13.4. Abitbol CL, Rodriguez MM. The long-term renal and cardio-
vascular consequences of prematurity. Nat Rev Nephrol 2012;
8:265e74.
5. Stapleton FB, Jones DP, Green RS. Acute renal failure in neo-
nates: incidence, etiology and outcome. Pediatr Nephrol 1987;
1:314e20.
6. Koralkar R, Ambalavanan N, Levitan EB, McGwin G, Goldstein S,
Askenazi D. Acute kidney injury reduces survival in very low
birth weight infants. Pediatr Res 2011;69:354e8.
7. Gouyon JB, Guignard JP. Management of acute renal failure in
newborns. Pediatr Nephrol 2000;14:1037e44.
8. Drukker A, Guignard JP. Renal aspects of the term and preterm
infant: a selective update. Curr Opin Pediatr 2002;14:175e82.
9. Vieux R, Hascoet JM, Merdariu D, Fresson J, Guillemin F.
Glomerular filtration rate reference values in very preterm
infants. Pediatrics 2010;125:e1186e92.
10. Abitbol CL, Seeherunvong W, Galarza MG, Katsoufis C,
Francoeur D, Defreitas M, et al. Neonatal kidney size and
function in preterm infants: what is a true estimate of
glomerular filtration rate? J Pediatr 2014;164:1026e31.
11. Kjeldsen L, Johnsen AH, Sengeløv H, Borregaard N. Isolation
and primary structure of NGAL, a novel protein associated
with human neutrophil gelatinase. J Biol Chem 1993;268:
10425e32.
12. Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C,
et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a
biomarker for acute renal injury after cardiac surgery. Lancet
2005;365:1231e8.
13. Dent CL, Ma Q, Dastrala S, Bennett M, Mitsnefes MM, Barasch J,
et al. Plasma neutrophil gelatinase-associated lipocalin pre-
dicts acute kidney injury, morbidity and mortality after pedi-
atric cardiac surgery: a prospective uncontrolled cohort study.
Crit Care 2007;11:R127.
14. Zappitelli M, Washburn KK, Arikan AA, Loftis L, Ma Q,
Devarajan P, et al. Urine neutrophil gelatinase-associated
lipocalin is an early marker of acute kidney injury in criti-
cally ill children: a prospective cohort study. Crit Care 2007;
11:R84.
15. Lavery AP, Meinzen-Derr JK, Anderson E, Ma Q, Bennett MR,
Devarajan P, et al. Urinary NGAL in premature infants. Pediatr
Res 2008;64:423e8.
16. Yilmaz A, Sevketoglu E, Gedikbasi A, Karyagar S, Kiyak A,
Mulazimoglu M, et al. Early prediction of urinary tract infection
with urinary neutrophil gelatinase associated lipocalin. Pediatr
Nephrol 2009;24:2387e92.
17. Devarajan P. Review: neutrophil gelatinase-associated lip-
ocalin: a troponin-like biomarker for human acute kidney
injury. Nephrology (Carlton) 2010;15:419e28.
18. Parravicini E. The clinical utility of urinary neutrophil
gelatinase-associated lipocalin in the neonatal ICU. Curr Opin
Pediatr 2010;22:146e50.
19. Inoue H, Ohga S, Kusuda T, Kitajima J, Kinjo T, Ochiai M, et al.
Serum neutrophil gelatinase-associated lipocalin as a predictor
of the development of bronchopulmonary dysplasia in preterm
infants. Early Hum Dev 2013;89:425e9.
20. Huynh TK, Bateman DA, Parravicini E, Lorenz JM,
Nemerofsky SL, Sise ME, et al. Reference values of urinary
neutrophil gelatinase-associated lipocalin in very low birth
weight infants. Pediatr Res 2009;66:528e32.
21. Parravicini E, Lorenz JM, Nemerofsky SL, O’Rourke M,
Barasch J, Bateman D. Reference range of urinary neutrophil
gelatinase-associated lipocalin in very low-birth-weight in-
fants: preliminary data. Am J Perinatol 2009;26:437e40.
22. Elmas AT, Tabel Y, Ipek S. Determination of reference values
for urinary neutrophil gelatinase-associated lipocalin in pre-
mature infants. J Matern Fetal Neonatal Med 2014;27:187e91.
23. Ricci Z, Ronco C. Neonatal RIFLE. Nephrol Dial Transplant
2013;28:2211e4.
212 C.-N. Chen et al24. Parravicini E, Nemerofsky SL, Michelson KA, Huynh TK, Sise ME,
Bateman DA, et al. Urinary neutrophil gelatinase-associated
lipocalin is a promising biomarker for late onset culture-
positive sepsis in very low birth weight infants. Pediatr Res
2010;67:636e40.
25. Rybi-Szuminska A, Wasilewska A, Litwin M, Kułaga Z,
Szuminski M. Paediatric normative data for urine NGAL/crea-
tinine ratio. Acta Paediatr 2013;102:e269e72.Appendix 1. Comparison of uNGAL levels in pret
Study (y) Participants uNGAL values (ng/
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Lavery
et al15 (2008)
20 By BBW
500e750 g (n Z 5)
750e1000 g (n Z 5)
1000e1250 g (n Z 5)
1250e1500 g (n Z 5)
Median (range)
123 (18.4e2815)
169.4 (91.7e1558.
31.9 (2.5e73.5)
17.9 (7.7e176.8)
Huynh
et al20 (2009)
50 By sex
All (n Z 50)
Male (n Z 30)
Female (n Z 20)
Median, 95th perc
and 99th percentil
5, 50, 120
5, 20, 40
10, 100, 135.2
Parravicini
et al21 (2009)
22 All were VLBW
infants
95th and 99th perc
25 and 75
Askenazi
et al1 (2011)
123 By GA
26 wk (n Z 52)
26e28 wk (n Z 30)
28e30 wk (n Z 23)
30e36 wk (n Z 18)
Geometric mean (
351 (271e456)
231 (161e333)
145 (96e218)
85 (53e134)
Elmas
et al22 (2014)
30 By GA
All (n Z 30)
28e29 wk (n Z 10)
30e32 wk (n Z 10)
33e34 wk (n Z 10)
Median (25e75% r
of PNA 1 d and 7
11.8 (1.97e27.2),
(0.98e15.9)
19.8 (8.6e25.7), 4
(1.02e22.6)
9.25 (1.42e30.3),
(0.96e17.8)
7.95 (1.6e27.8), 4
(0.79e16.0)
This study 24 By GA
All (n Z 24)
<32 wk (n Z 11)
32 wk (n Z 13)
Median of PNA 3 d
14 d, and 21 d
41.52, 35.82, 43.7
30.85
56.8, 45.6, 44.7, 3
37.6, 34.1, 39.8, 2
AKIZ acute kidney injury; BBWZ birth body weight; CIZ confidence
PNA Z postnatal age; uNGAL Z urinary neutrophil gelatinase-associa26. Keijzer-Veen MG, Devos AS, Meradji M, Dekker FW, Nauta J,
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Devarajan P. Neutrophil gelatinase-associated lipocalin con-
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mL) How to collect the urine Comments
8)
Collected everyday for
the first 14 d of life by
cotton ball or bladder
catheter
1. AKI, sepsis, and NEC
patients were included.
2. The uNGAL levels are
higher at earlier GA and
lower BBW
entile,
e
Collected from PNA 4 d
to 30 d by urine bag
1. With uncomplicated
clinical course
2. The uNGAL levels
were higher in female
infants
entile Collected on PNA 3 d, 7
d, 14 d, and 21 d by urine
bag
With uncomplicated
clinical course
95% CI) Collected during the first
7 postnatal days by
cotton balls
1. Patients with AKI were
enrolled.
2. The uNGAL values
decreased with
increasing GA and were
higher in female
ange)
d
3.65
.85
2.0
.4
Collected on PNA 1 d and
7 d by urine bag or
urinary catheter
1. With uncomplicated
clinical course
2. The uNGAL values
were not associated with
GA, BBW, sex.
, 7 d,
9,
2.3
8.2
Collected on PNA 3 d, 7
d, 14 d, and 21 d by urine
bag or cotton balls
1. With uncomplicated
clinical course
2. The uNGAL were not
associated with GA,
BBW, PNA, and sex
interval; GAZ gestational age; NECZ necrotizing enterocolitis;
ted lipocalin; VLBW Z very low birth weight.
